EirGen Pharma oncology molecule Eir-010 successfully completes clinical trial

EirGen Pharma are pleased to announce that their oncology molecule "Eir-010" has successfully completed clinical studies in March 2008.

EirGen Pharma`s Technical Director Tom Brennan stated that "this is a significant achievement for EirGen as it continues to demonstrate our committment to delivering innovative high potency pharmaceutical products for global markets". Managing Director Patsy Carney commented "this latest successful clinical trial highlights EirGen`s ability to deliver niche products and adds to our portfolio of oncology molecules across multiple markets".

EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets